Преглед наслова:

Приказ резултата 1532-1551 од 1806

      Наслови
      T cells cooperate with palmitic acid in induction of beta cell apoptosis [1]
      Tailoring conservation to suit Serbian spruce [1]
      Tailoring the physico-chemical and antimicrobial properties of agar-based films by in situ formation of Cu-mineral phase [1]
      Targeted mutational profiling of childhood and adult acute lymphoblastic leukemia patients [1]
      Targeted next generation sequencing (ngs) in parallel analyses of childhood (caml) and adult acute myeloid leukemia (AAML) patients [1]
      Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis [1]
      Technical overview of nuclear microsatellites for Fagus sp., and their utility in F. sylvatica from the central Balkans (Serbia) [1]
      Techno-Functional Performance of Emmer, Spelt and Khorasan in Spontaneously Fermented Sourdough Bread [1]
      Technological and probiotic potential of BGRA43 a natural isolate of Lactobacillus helveticus [1]
      Telomere-associated chromosome fragmentation: Applications in genome manipulation and analysis [1]
      Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates [1]
      Tenascin-C fibronectin D domain is involved in the fine-tuning of glial response to CNS injury in vitro [1]
      TetR family member PsrA directly binds the Pseudomonas rpoS and psrA promoters [1]
      Tetrahydrobiopterin deficiency among Serbian patients presenting with hyperphenylalaninemia [1]
      Tetraoxanes as inhibitors of apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii growth and anti-cancer molecules [1]
      Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies) [1]
      TG-interacting Factor (TGIF) Downregulates SOX3 Gene Expression in the NT2/D1 Cell Line [1]
      TGFB1 Gene Promoter Polymorphisms in Serbian Asthmatics [1]
      Thalassemia syndromes in Serbia: an update [1]
      The 'VKORC1' and 'CYP2C9' gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients: Consideration of hypersensitivity and resistance [1]